Skip to main content
. 2024 May 22;21(6):662. doi: 10.3390/ijerph21060662
anti-CCP anti-cyclic citrullinated peptide
CVD cardiovascular disease
DM diabetes mellitus
DMARDs disease-modifying antirheumatic drugs
eHealth digital health
EHR electronic health record
GCs glucocorticoids
G-CSF granulocyte colony-stimulating factor
GPs general practitioners
IA inflammatory arthritis
INF-gamma interferon-gamma
IL-1 interleukin-1
IL-4 interleukin-4
IL-5 interleukin-5
IL-6 interleukin-6
IL-8 interleukin-8
IL-10 interleukin-10
IL-12 interleukin-12
IL-13 interleukin-13
IL-17 interleukin-17
IL-21 interleukin-21
IL-21 interleukin-22
IL-35 interleukin-35
MSK musculoskeletal
MTX methotrexate
NPs nurse practitioners
PC primary care
PsA psoriatic arthritis
RA rheumatoid arthritis
RANKL receptor activator of nuclear factor kappa-Β
RCTs randomized controlled trials
RF rheumatoid factor
SpA spondylarthritis
TGF-beta transforming grow factor-beta
TNF-alfa tumor necrosis factor-alfa